Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (241-250 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|January 4, 2019
ECHELON-2 - brentuximab raises PTCL outcomes to new levelsDavid Killock
Nature Reviews. Clinical Oncology|December 6, 2017
Immunotherapy: New or second CARs for ALLDavid Killock
Nature Reviews. Clinical Oncology|December 22, 2019
ALCYONE - lighting the way for quadruplet therapy of NDMMDavid Killock
Nature Reviews. Clinical Oncology|June 29, 2023
New anti-angiogenic option for mCRCDavid Killock
Nature Reviews. Clinical Oncology|July 27, 2021
CAR T cells show promise in mesotheliomaDavid Killock
Nature Reviews. Urology|February 19, 2014
Bladder cancer: Support added for neoadjuvant therapy in MIBCDavid Killock
Nature Reviews. Clinical Oncology|February 5, 2014
Kidney cancer: sunitinib has similar efficacy irrespective of age in mRCCDavid Killock
Nature Reviews. Clinical Oncology|September 1, 2019
A new standard for EGFR-mutant NSCLC?David Killock
Nature Reviews. Clinical Oncology|August 3, 2016
Haematological cancer: CTLA-4 blockade after allo-SCTDavid Killock
Nature Reviews. Clinical Oncology|June 17, 2015
Skin cancer: T-VEC oncolytic viral therapy shows promise in melanomaDavid Killock
Pageof 31

Showing results (241-250 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|January 4, 2019
ECHELON-2 - brentuximab raises PTCL outcomes to new levelsDavid Killock
Nature Reviews. Clinical Oncology|December 6, 2017
Immunotherapy: New or second CARs for ALLDavid Killock
Nature Reviews. Clinical Oncology|December 22, 2019
ALCYONE - lighting the way for quadruplet therapy of NDMMDavid Killock
Nature Reviews. Clinical Oncology|June 29, 2023
New anti-angiogenic option for mCRCDavid Killock
Nature Reviews. Clinical Oncology|July 27, 2021
CAR T cells show promise in mesotheliomaDavid Killock
Nature Reviews. Urology|February 19, 2014
Bladder cancer: Support added for neoadjuvant therapy in MIBCDavid Killock
Nature Reviews. Clinical Oncology|February 5, 2014
Kidney cancer: sunitinib has similar efficacy irrespective of age in mRCCDavid Killock
Nature Reviews. Clinical Oncology|September 1, 2019
A new standard for EGFR-mutant NSCLC?David Killock
Nature Reviews. Clinical Oncology|August 3, 2016
Haematological cancer: CTLA-4 blockade after allo-SCTDavid Killock
Nature Reviews. Clinical Oncology|June 17, 2015
Skin cancer: T-VEC oncolytic viral therapy shows promise in melanomaDavid Killock
Pageof 31